Filed: 11/14/2023ACC: 0000921895-23-002627
📋 What this filing means
MEMORIAL SLOAN KETTERING CANCER CENTER filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $24.56M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$24.56M
Total AUM (reported)
1.53M
Total Shares
Allocation by class
GOLD MINERS ETF$19.87M80.9%
COM$4.69M19.1%
Portfolio Concentration
Top 3$24.56M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 1.53M
Sole
Full voting authority
1.53M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole3
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings3
Rows:
VANECK ETF TRUST
SOLEShares738.50K
TypeSH
Market value$19.87M
80.92%
Sole
738.50K
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares602.27K
TypeSH
Market value$3.64M
14.84%
Sole
602.27K
Shared
0.00
None
0.00
Y-MABS THERAPEUTICS INC
SOLEShares191.18K
TypeSH
Market value$1.04M
4.24%
Sole
191.18K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
VANECK ETF TRUSTSOLE | GOLD MINERS ETF | 738.50K | SH | $19.87M 80.92% | 738.50K | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 602.27K | SH | $3.64M 14.84% | 602.27K | 0.00 | 0.00 |
Y-MABS THERAPEUTICS INCSOLE | COM | 191.18K | SH | $1.04M 4.24% | 191.18K | 0.00 | 0.00 |